CNR2 and intervertebral disk degenerative disorder: Taken together, this evidence suggests that agents which can activate CB1 and CB2 may help decrease SBPs and aggression in adults with IDD given the essential roles of endocannabinoid and neuroimmune systems in a multitude of behavioral functions associated with aggression.